Haemoglobin Fontainebleau (HBA2: C. 64G>C) in Oman: Molecular and haematological characteristics and interaction with various haemoglobinopathies

Shahina Daar, Shoaib Al Zadjali, Salam Alkindi, Yasser Wali, Abdulhakeem Al-Rawas, Humood Al-Haddabi, Arwa Z. Al-Riyami

Research output: Contribution to journalArticle

Abstract

Objectives To describe the laboratory features of haemoglobin Fontainebleau (Hb FB) and its interactions with various α and β globin gene mutations in the Omani population. Methods Over a period of 10 years, a total of 94 blood samples were suspected to have an α variant on HPLC at the Sultan Qaboos University Hospital, Muscat, Oman. Molecular testing was performed using PCR based techniques to define the variant and to analyse other interacting mutations in either α or β globin genes. Results Of 94 subjects, molecular analysis confirmed the Hb FB variant in 55 samples (38 non-cord and 17 cord blood). A total of 36/38 non-cord samples were heterozygous for the variant, while all 17 cord blood samples were heterozygotes. A total of 43/55 individuals had a concomitant α and/or β globin gene mutation. Conclusions Hb FB is the the most common α variant in the Omani population. We report the different HPLC profiles of this variant that we observed, with and without other haemoglobinopathies in non-cord and cord blood samples. This is the first report describing the HPLC profiles of this α globin chain variant on 1 year follow-up testing of cord blood samples. With careful analysis by HPLC, it is possible not only to identify Hb FB but also to predict any concomitant α and/or β globin gene mutations.

Original languageEnglish
Pages (from-to)303-308
Number of pages6
JournalJournal of Clinical Pathology
Volume71
Issue number4
DOIs
Publication statusPublished - Apr 1 2018

Fingerprint

Oman
Hemoglobinopathies
Globins
Fetal Blood
High Pressure Liquid Chromatography
Mutation
Genes
Heterozygote
Population
hemoglobin Fontainebleau
Polymerase Chain Reaction

Keywords

  • Diagnosis
  • Diagnostic Screening
  • Haemoglobinopathy

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Haemoglobin Fontainebleau (HBA2 : C. 64G>C) in Oman: Molecular and haematological characteristics and interaction with various haemoglobinopathies. / Daar, Shahina; Al Zadjali, Shoaib; Alkindi, Salam; Wali, Yasser; Al-Rawas, Abdulhakeem; Al-Haddabi, Humood; Al-Riyami, Arwa Z.

In: Journal of Clinical Pathology, Vol. 71, No. 4, 01.04.2018, p. 303-308.

Research output: Contribution to journalArticle

@article{55185169b0c14e369315abcb23bbf6cc,
title = "Haemoglobin Fontainebleau (HBA2: C. 64G>C) in Oman: Molecular and haematological characteristics and interaction with various haemoglobinopathies",
abstract = "Objectives To describe the laboratory features of haemoglobin Fontainebleau (Hb FB) and its interactions with various α and β globin gene mutations in the Omani population. Methods Over a period of 10 years, a total of 94 blood samples were suspected to have an α variant on HPLC at the Sultan Qaboos University Hospital, Muscat, Oman. Molecular testing was performed using PCR based techniques to define the variant and to analyse other interacting mutations in either α or β globin genes. Results Of 94 subjects, molecular analysis confirmed the Hb FB variant in 55 samples (38 non-cord and 17 cord blood). A total of 36/38 non-cord samples were heterozygous for the variant, while all 17 cord blood samples were heterozygotes. A total of 43/55 individuals had a concomitant α and/or β globin gene mutation. Conclusions Hb FB is the the most common α variant in the Omani population. We report the different HPLC profiles of this variant that we observed, with and without other haemoglobinopathies in non-cord and cord blood samples. This is the first report describing the HPLC profiles of this α globin chain variant on 1 year follow-up testing of cord blood samples. With careful analysis by HPLC, it is possible not only to identify Hb FB but also to predict any concomitant α and/or β globin gene mutations.",
keywords = "Diagnosis, Diagnostic Screening, Haemoglobinopathy",
author = "Shahina Daar and {Al Zadjali}, Shoaib and Salam Alkindi and Yasser Wali and Abdulhakeem Al-Rawas and Humood Al-Haddabi and Al-Riyami, {Arwa Z.}",
year = "2018",
month = "4",
day = "1",
doi = "10.1136/jclinpath-2017-204617",
language = "English",
volume = "71",
pages = "303--308",
journal = "Journal of Clinical Pathology - Clinical Molecular Pathology",
issn = "0021-9746",
publisher = "BMJ Publishing Group",
number = "4",

}

TY - JOUR

T1 - Haemoglobin Fontainebleau (HBA2

T2 - C. 64G>C) in Oman: Molecular and haematological characteristics and interaction with various haemoglobinopathies

AU - Daar, Shahina

AU - Al Zadjali, Shoaib

AU - Alkindi, Salam

AU - Wali, Yasser

AU - Al-Rawas, Abdulhakeem

AU - Al-Haddabi, Humood

AU - Al-Riyami, Arwa Z.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Objectives To describe the laboratory features of haemoglobin Fontainebleau (Hb FB) and its interactions with various α and β globin gene mutations in the Omani population. Methods Over a period of 10 years, a total of 94 blood samples were suspected to have an α variant on HPLC at the Sultan Qaboos University Hospital, Muscat, Oman. Molecular testing was performed using PCR based techniques to define the variant and to analyse other interacting mutations in either α or β globin genes. Results Of 94 subjects, molecular analysis confirmed the Hb FB variant in 55 samples (38 non-cord and 17 cord blood). A total of 36/38 non-cord samples were heterozygous for the variant, while all 17 cord blood samples were heterozygotes. A total of 43/55 individuals had a concomitant α and/or β globin gene mutation. Conclusions Hb FB is the the most common α variant in the Omani population. We report the different HPLC profiles of this variant that we observed, with and without other haemoglobinopathies in non-cord and cord blood samples. This is the first report describing the HPLC profiles of this α globin chain variant on 1 year follow-up testing of cord blood samples. With careful analysis by HPLC, it is possible not only to identify Hb FB but also to predict any concomitant α and/or β globin gene mutations.

AB - Objectives To describe the laboratory features of haemoglobin Fontainebleau (Hb FB) and its interactions with various α and β globin gene mutations in the Omani population. Methods Over a period of 10 years, a total of 94 blood samples were suspected to have an α variant on HPLC at the Sultan Qaboos University Hospital, Muscat, Oman. Molecular testing was performed using PCR based techniques to define the variant and to analyse other interacting mutations in either α or β globin genes. Results Of 94 subjects, molecular analysis confirmed the Hb FB variant in 55 samples (38 non-cord and 17 cord blood). A total of 36/38 non-cord samples were heterozygous for the variant, while all 17 cord blood samples were heterozygotes. A total of 43/55 individuals had a concomitant α and/or β globin gene mutation. Conclusions Hb FB is the the most common α variant in the Omani population. We report the different HPLC profiles of this variant that we observed, with and without other haemoglobinopathies in non-cord and cord blood samples. This is the first report describing the HPLC profiles of this α globin chain variant on 1 year follow-up testing of cord blood samples. With careful analysis by HPLC, it is possible not only to identify Hb FB but also to predict any concomitant α and/or β globin gene mutations.

KW - Diagnosis

KW - Diagnostic Screening

KW - Haemoglobinopathy

UR - http://www.scopus.com/inward/record.url?scp=85044178492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044178492&partnerID=8YFLogxK

U2 - 10.1136/jclinpath-2017-204617

DO - 10.1136/jclinpath-2017-204617

M3 - Article

C2 - 28784617

AN - SCOPUS:85044178492

VL - 71

SP - 303

EP - 308

JO - Journal of Clinical Pathology - Clinical Molecular Pathology

JF - Journal of Clinical Pathology - Clinical Molecular Pathology

SN - 0021-9746

IS - 4

ER -